Autophagy in cardiac pathophysiology: Navigating the complex roles and therapeutic potential in cardiac fibrosis

Area of Science:

• Cardiology
• Cellular Biology
• Pathology

Background:

• Cardiac fibrosis, characterized by excessive extracellular matrix deposition, is a major driver of cardiac dysfunction in cardiovascular diseases like heart failure and myocardial infarction.
• Autophagy, a crucial cellular process for degrading damaged components, is vital for maintaining cardiac homeostasis and preventing cellular damage.

Purpose of the Study:

• To review the intricate role of autophagy in the development and progression of cardiac fibrosis.
• To explore potential pharmacological strategies targeting autophagy for the treatment of cardiac fibrosis.

Main Methods:

• Literature review of recent studies on autophagy and cardiac fibrosis.
• Analysis of the mechanisms by which autophagy influences fibroblast activation and extracellular matrix accumulation.
• Examination of therapeutic interventions aimed at modulating autophagic pathways in cardiac fibrosis.

Main Results:

• Autophagic dysregulation can significantly exacerbate cardiac fibrosis by promoting fibroblast activation and extracellular matrix deposition.
• Proper autophagic activity demonstrates a protective role by clearing damaged cellular components and regulating fibrotic signaling pathways.
• Pharmacological modulation of autophagy presents a promising avenue for therapeutic intervention in cardiac fibrosis.

Conclusions:

• Autophagy is a critical regulator of cardiac fibrosis, with its dysregulation contributing to disease progression.
• Targeting autophagy pathways offers potential therapeutic strategies to attenuate cardiac fibrosis and improve cardiac function.
• Further research into autophagy modulation could lead to novel treatments for cardiovascular diseases associated with fibrosis.